atherosclerotic lesions
Localization of distinct F2 isoprostanes in human atherosclerotic lesions
8
Increased ferritin gene expression in atherosclerotic lesions
10
Presence of hypochlorite modified proteins in human atherosclerotic lesions
11
Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions
11
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
13
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
9
Transcatheter treatment of atherosclerotic lesions of the brain complicated by vascular dementia development
10
Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions
8
New mechanism for foam cell generation in atherosclerotic lesions
8
Decreased type II/type I TGF beta receptor ratio in cells derived from human atherosclerotic lesions Conversion from an antiproliferative to profibrotic response to TGF beta1
10
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation
11
Residual Stresses Computing in Blood Vessels in virtue of Pathological Growth Processes
5
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
12
Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE deficient mice
11
Overexpression of complement component C5a accelerates the development of atherosclerosis in ApoE-knockout mice
11
Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress
12
Dual Antiplatelet Therapy Monitoring for Neurointerventional Procedures Using a Point of Care Platelet Function Test: A Single Center Experience
6
Mathematical and numerical modeling of early atherosclerotic lesions*,**
14
Original Article Effects of Smad decoy ODN on shear stress-induced atherosclerotic ApoE-/-mouse
8
Myricetin and Hesperidin Inhibit Cerebral Thrombogenesis and Atherogenesis in Apoe / and Ldlr / Mice
12